- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 18-12-2025: Press Release
18-12-2025 | 03:41 pm
18-12-2025 | 03:41 pm
Lupin's subsidiaries signed an exclusive licensing deal with Neopharmed for Plasil®, a gastroenterology brand, in the Philippines and Brazil. This strengthens Lupin's portfolio and expands its presence in these emerging markets. Production for Brazil will shift to Lupin's facility.
No comments yet. Be the first to comment!